Bio‑Rad Execs Trade in Balanced Style as Company Eyes New Analytics‑Driven Oncology Boost
Insider buying signals cautious optimism at Bio‑Rad Laboratories, as executives quietly add to their stake amid a new analytics partnership that could boost its oncology pipeline.
3 minutes to read